Mitigating Risk Through Product Characterization
Source: MilliporeSigma
In this webinar, multiple approaches to characterizing the physico-chemical and structural attributes of therapeutic mAbs is presented with a focus on how it influences the resulting biological activity.
- Characterization of therapeutic antibodies
- what, why, and when
- Benefits of early use of PC approaches to understand your product
- Complexities of monoclonal (mAbs) and their characterization
- Approaches to characterization of mAb physico-chemical and structural attributes
- Functional characterization of mAbs
VIEW THE WEBINAR!
Log In
Signing up provides unlimited access to:
Free Sign Up

Signing up provides unlimited access to:
- Trend and Leadership Articles
- Case Studies
- Extensive Product Database
- Premium Content
HELLO. PLEASE LOG IN.
X
Not yet a member of BioProcess Online? Register today.
ACCOUNT SIGN UP
X
Please fill in your account details
ACCOUNT SIGN UP
MilliporeSigma
This website uses cookies to ensure you get the best experience on our website. Learn more